Dyne Therapeutics, Inc. · NASDAQ:DYN
Kerr Douglas sold 5,035 Dyne Therapeutics, Inc. shares (Form 4)
Traded Sep 4 to Sep 8, 2026 · Filed Sep 8, 2026
From Sep 4 to Sep 8, 2026, Kerr Douglas (Chief Medical Officer) sold 5,035 Dyne Therapeutics, Inc. shares at an average US$22.95 for US$116K under a trading plan, leaving 162,564 shares. Filed Sep 8, 2026 (Form 4).
- Sold
- 5,035 shares
- Price
- US$22.95 average (US$18.88 to US$24.35)
- Value
- US$116K
- Holding after
- 162,564 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Common Stock | Sale | 3,745 | US$24.35 | 163,854 | Direct |
| Sep 8, 2026 | Common Stock | Sale | 1,290 | US$18.88 | 162,564 | Direct |
Source
Related
- Dyne Therapeutics, Inc.
- Kerr Douglas
- Dyne Therapeutics, Inc. shareholders
- Form 4 · Kerr Douglas · Aug 17, 2026
- Form 4 · Kerr Douglas · Jun 17, 2026
- Form 4 · Kerr Douglas · May 14, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Rhodes Jason P · Aug 17, 2026
- Form 4 · Cox John · Aug 17, 2026